Invention Grant
- Patent Title: Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor
-
Application No.: US14949303Application Date: 2015-11-23
-
Publication No.: US09943596B2Publication Date: 2018-04-17
- Inventor: Jimin Lee , Bo Gyou Kim , Seungja Oh , Kyung Ah Kim , Powei Lin , Saet Byoul Lee
- Applicant: Samsung Electronics Co., Ltd.
- Applicant Address: KR Suwon-si
- Assignee: SAMSUNG ELECTRONICS CO., LTD.
- Current Assignee: SAMSUNG ELECTRONICS CO., LTD.
- Current Assignee Address: KR Suwon-si
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: KR10-2014-0163791 20141121
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/4985 ; G01N33/574 ; A61K31/00 ; C07K16/28 ; G01N33/74 ; A61K39/00
Abstract:
A method of preventing and/or treating a cancer, the method including co-administering a dual inhibitor of c-Met and EGFR (hereinafter, ‘c-Met/EGFR dual inhibitor’) and an IGF-1R inhibitor to a subject in need thereof and a use of IGF-1R as a marker for resistance to a c-Met/EGFR dual inhibitor.
Public/Granted literature
- US20160144028A1 COMBINATION THERAPY USING DUAL INHIBITOR OF C-MET AND EGFR AND IGF-1R INHIBITOR Public/Granted day:2016-05-26
Information query
